Pre- or postoperative radiotherapy for soft tissue sarcomas
- PMID: 32807685
- DOI: 10.1016/j.canrad.2020.05.007
Pre- or postoperative radiotherapy for soft tissue sarcomas
Abstract
Sarcomas are rare tumours arising from mesenchymal tissue. A multimodal management in an expert centre combining surgery and radiotherapy is the current standard of care for localized soft-tissue sarcomas of the extremities, to enable limb-sparing strategies. The delivery of pre- radiotherapy or postoperative radiotherapy offers similar local control and survival rates but the toxicity profile is quite different: preoperative radiotherapy increases the risk of wound complications and postoperative radiotherapy affects long-term functional outcomes. While postoperative radiotherapy has long been the rule, especially in Europe, technical improvements with image-guided- and intensity-modulated radiotherapy associated with a better management of postoperative wounds has tended to change practices with more frequent preoperative radiotherapy. More recently the possibilities of a hypofractionated regimen or potentiation by nanoparticles to increase the therapeutic index plead in favour of a preoperative delivery of radiotherapy. The aim of this paper is to report pros and cons of pre- and post-operative radiotherapy for soft-tissue sarcomas.
Keywords: Biopsie; Biopsy; Chirurgie; Imagerie; Imaging; Postoperative; Postopératoire; Preoperative; Préopératoire; Radiotherapy; Radiothérapie; Sarcomes des tissus mous; Soft-tissue sarcomas; Surgery.
Copyright © 2020. Published by Elsevier Masson SAS.
Similar articles
-
Conformal radiotherapy in management of soft tissue sarcoma in adults.Cancer Radiother. 2022 Feb-Apr;26(1-2):377-387. doi: 10.1016/j.canrad.2021.11.023. Epub 2021 Dec 24. Cancer Radiother. 2022. PMID: 34961656
-
[Radiotherapy of adult soft tissue sarcoma].Cancer Radiother. 2016 Sep;20 Suppl:S235-43. doi: 10.1016/j.canrad.2016.07.028. Epub 2016 Aug 11. Cancer Radiother. 2016. PMID: 27523415 French.
-
[Rôle of radiotherapy for sarcomas].Cancer Radiother. 2021 Oct;25(6-7):598-602. doi: 10.1016/j.canrad.2021.06.008. Epub 2021 Jun 29. Cancer Radiother. 2021. PMID: 34215521 Review. French.
-
Soft tissue sarcoma of the extremities: pending questions on surgery and radiotherapy.Radiat Oncol. 2016 Oct 12;11(1):136. doi: 10.1186/s13014-016-0668-9. Radiat Oncol. 2016. PMID: 27733179 Free PMC article. Review.
-
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial.Lancet Oncol. 2022 Dec;23(12):1547-1557. doi: 10.1016/S1470-2045(22)00638-6. Epub 2022 Nov 4. Lancet Oncol. 2022. PMID: 36343656 Free PMC article. Clinical Trial.
Cited by
-
Ultrahypofractionated Versus Normofractionated Preoperative Radiotherapy for Soft Tissue Sarcoma: A Multicenter, Prospective Real-World-Time Phase 2 Clinical Trial.Cancers (Basel). 2024 Dec 4;16(23):4063. doi: 10.3390/cancers16234063. Cancers (Basel). 2024. PMID: 39682249 Free PMC article.
-
What is the optimal (neo)adjuvant strategy of extremity high-risk soft tissue sarcomas (ESTS)?Med Oncol. 2023 Dec 12;41(1):16. doi: 10.1007/s12032-023-02240-1. Med Oncol. 2023. PMID: 38087013
-
Two Different Types of Sarcoma Occurring Synchronously: The Impact of Molecular Biology on Therapeutic Strategy.Cureus. 2022 Jan 26;14(1):e21626. doi: 10.7759/cureus.21626. eCollection 2022 Jan. Cureus. 2022. PMID: 35233308 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous